← Open Payments lookup

CHARLAI BREEDING: Open Payments

NPI 1477262954 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,983 in 156 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,051 · 2025 $2,983

Food & beverage: $2,983
CompanyPaymentsAmount
ABBVIE INC.20$322
QOL Medical, LLC12$308
GENZYME CORPORATION11$275
Lilly USA, LLC13$241
Regeneron Healthcare Solutions, Inc.10$236
Ardelyx, Inc.9$207
Madrigal Pharmaceuticals9$183
Takeda Pharmaceuticals U.S.A., Inc.12$178
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$167
Janssen Biotech, Inc.8$145

Products named: DUPIXENT, Sucraid, OMVOH, IBSRELA, REZDIFFRA, TREMFYA, CREON, IQIRVO.

Industry payments across AL — which companies pay providers there.